Skip to content

Drug interactions

Dabigatran etexilate + Ranolazine

Severity: Moderate

Dabigatran etexilate and Ranolazine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ranolazine is a weak P-glycoprotein inhibitor and may modestly increase dabigatran exposure. This could raise bleeding risk, particularly in patients with impaired renal function.

What this interaction means in plain words

Dabigatran etexilate and Ranolazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dabigatran etexilate belongs to Cardiovascular; Ranolazine belongs to Cardiovascular.

Evidence level: Low

Why it happens

Ranolazine inhibits intestinal P-glycoprotein, reducing efflux of dabigatran etexilate and increasing its absorption.

What to do

Monitor for bleeding and check renal function before and during combined therapy. Avoid the combination if creatinine clearance is markedly reduced.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dabigatran etexilate and Ranolazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dabigatran etexilate with Ranolazine?

MediHelp rates the interaction as moderate. Dabigatran etexilate and Ranolazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ranolazine is a weak P-glycoprotein inhibitor and may modestly increase dabigatran exposure. This could raise bleeding risk, particularly in patients with impaired renal function.

How serious is the interaction between Dabigatran etexilate and Ranolazine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for bleeding and check renal function before and during combined therapy. Avoid the combination if creatinine clearance is markedly reduced.

What other medicines interact with Dabigatran etexilate?

MediHelp also lists interactions of Dabigatran etexilate with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Dabigatran etexilate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in